Steve Keane

Steve Keane

Morrison & Foerster LLP

Contact
View Bio
RSS

Latest Posts › BPCIA

Share:

FDA Approves 25th Biosimilar

On November 15, 2019, FDA approved Pfizer’s adalimumab product, a biosimilar to AbbVie’s Humira, marking the 25th approval of a biosimilar under the Biologics Price Competition and Innovation Act (BPCIA). A biosimilar is a...more

11/21/2019  /  Biosimilars , BPCIA , Food and Drug Administration (FDA) , Life Sciences , Patent Dance , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents , Popular
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide